Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:59 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 481–504 of 4,175 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control comparison Clear all

Conditions: Brain Tumor, Brain Necrosis, Brain Metastases, Glioma
Interventions: MRF in conjunction with IVIM MRI without contrast; Procedure
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years to 60 Years
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Cleveland, Ohio

Conditions: Atrial Fibrillation, Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
Interventions: OPC-108459, Placebo; Drug
Lead sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 9
States / cities: Washington D.C., District of Columbia • Hollywood, Florida • Jacksonville, Florida + 6 more

Conditions: Asthma
Interventions: Placebo, FP 100mcg, FP 250mcg, FP 500mcg, FSC 100/50mcg, FSC 250/50mcg, FSC500/50mcg; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 12 Years and older
Enrollment: 446 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 51
States / cities: Birmingham, Alabama • Jasper, Alabama • Glendale, Arizona + 43 more

Conditions: Ankle Osteoarthritis
Interventions: Axolotl Ambient, "Drug/Placebo: 0.9% Normal Saline"; Biological · Drug
Lead sponsor: Axolotl Biologix; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 3
States / cities: Boise, Idaho • Shreveport, Louisiana • Charlotte, North Carolina

Conditions: Pediatric Immuno-Tolerant Chronic Hepatitis B
Interventions: Entecavir, Lamivudine, Pegylated Interferon Alfa-2A; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 3 Years to 17 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 3
States / cities: Kansas City, Missouri • New York, New York • Philadelphia, Pennsylvania

Conditions: Vulvar and Vaginal Atrophy
Interventions: Estradiol Vaginal Tablets 10 mcg (Glenmark), Vagifem® (Estradiol Vaginal Tablets) 10 mcg (Novo Nordisk), Placebo of Estradiol Vaginal Tablets 10 mcg (Glenmark); Drug
Lead sponsor: Glenmark Pharmaceuticals Ltd. India; Industry
Eligibility: 30 Years to 75 Years · Female only
Enrollment: 522 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Mahwah, New Jersey

Conditions: Fluid Overload, POCUS, Lung Ultrasound, Volume Status
Interventions: point-of-care ultrasound (POCUS), specifically lung ultrasound (LUS), Modified Medical Research Council (mMRC) Dyspnea scale, Physical Exam; Device · Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Pain, Postoperative, Otitis Media
Interventions: Ketorolac, Fentanyl; Drug
Lead sponsor: Anica Crnkovic; Other
Eligibility: 8 Months to 7 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 1
States / cities: Albany, New York

Conditions: Communication
Interventions: First year program, Control comparison; Behavioral · Other
Lead sponsor: Jennifer McCallister MD; Other
Eligibility: 18 Years to 89 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Muscle Soreness, Muscle Weakness, Muscle Tenderness
Interventions: Kettlebell Swing, Isometric Hold, Control; Other
Lead sponsor: University of Central Florida; Other
Eligibility: 18 Years to 35 Years
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Follicular Lymphoma
Interventions: Rituximab, Lenalidomide, Rituximab-CHOP, Rituximab-CVP, Rituximab-Bendamustine; Drug
Lead sponsor: Celgene; Industry
Eligibility: 18 Years and older
Enrollment: 1,030 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2024
U.S. locations: 26
States / cities: Chandler, Arizona • Fullerton, California • Los Angeles, California + 21 more

Conditions: Smoking Cessation, Bipolar Disorder
Interventions: Varenicline, Placebo; Drug
Lead sponsor: K.N. Roy Chengappa; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 2
States / cities: DuBois, Pennsylvania • Pittsburgh, Pennsylvania

Conditions: Hypertension
Interventions: Telemedicine management of Hypertension, Usual Care; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Skin Wrinkles on Face and Neck Areas
Interventions: Activation Mist; Other
Lead sponsor: California Allergy and Asthma Medical Group, Inc.; Other
Eligibility: 30 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Anxiety, Anxiety Disorders, Anxiety Neuroses, Anxiety States
Interventions: Placebo, quetiapine fumarate XR; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 409 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 53
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Beverly Hills, California + 50 more

Conditions: Sickle Cell Disease
Interventions: Brigance Preschool Screen -II; Other
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 3 Years to 4 Years
Enrollment: 248 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Normothermia, Intraoperative Temperature, Anesthesia
Interventions: AVACore Technologies, Inc. warmUP Sleeve, Arizant Healthcare Bair Hugger®; Device
Lead sponsor: Tampa General Hospital; Other
Eligibility: 18 Years to 80 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Older Adults, Fall Patients
Interventions: Lateral stepping, Forward walking; Behavioral
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years to 90 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Healthy
Interventions: Eggs; Other
Lead sponsor: Tufts University; Other
Eligibility: 50 Years to 70 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Glycemic Control
Interventions: Fasiglifam (TAK-875), Sitagliptin, Placebo; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years and older
Enrollment: 916 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 58
States / cities: Muscle Shoals, Alabama • Mesa, Arizona • Peoria, Arizona + 55 more

Conditions: Vaccine, Human Papiloma Virus Vaccine, HPV Vaccine, Immunization, Health Registry, Adolescent Health, Reproductive Health, Preventive Health Services
Interventions: Vaccine Reminder/Recall; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 11 Years to 17 Years
Enrollment: 77,716 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: COPD, Obesity & Overweight, Sarcopenia
Interventions: Tirzepatide; Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 40 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Epilepsy, Adherence, Medication
Interventions: Automated Digital Reminders, Individualized Adherence Feedback Report, Individual Adherence Feedback Report with Social Norms; Behavioral
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 13 Years to 17 Years
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Urinary Tract Infections
Interventions: Multiplex-PCR with Pooled Antibiotic Susceptibility Testing (M-PCR/P-AST), Urine Culture; Diagnostic Test
Lead sponsor: Pathnostics; Industry
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Barrington, Illinois

Search by objective public record fields.

Development of MRF for Characterization of Brain Tumors After Radiotherapy

Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation

GSK BHR Study (Sont - Second Study)

Evaluating Intra-articular Injection of Axolotl Ambient Compared to Saline in Subjects With Ankle Osteoarthritis

A Study of Pegylated Interferon Alfa-2A in Combination With Lamivudine or Entecavir Compared With Untreated Control Group in Children With Hepatitis B Envelope Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) in the Immune-Tolerant Phase

To Study Generic Estradiol 10 mcg Vaginal Tablets in the Treatment of Vulvar and Vaginal Atrophy in Post Menopausal Women.

Concordance and Discordance in the Assessment of Volume Status in Home Dialysis Patients: A Comparison of Modified Medical Research Council Dyspnea Scale, Physical Exam, and Point of Care Ultrasound (POCUS)

Ketorolac Sublingual vs. Fentanyl Intranasal in Pain Control for Bilateral Myringotomy and Tubes (BMT) Placement in Children

Communication Skills Training and Competency Assessment for Pulmonary and Critical Care Medicine Fellows

Lumbosacral Muscle Sensitivity & Pressure Pain Threshold After Kettlebell Swings

Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma

Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder

Tailoring TM-HTN Intervention for Black Patients

Study to Determine Effectiveness of Activation Mist on Facial Skin Wrinkles

Generalized Anxiety Disorder Adjunct Study

The Brigance Assessment Of Individual Neurodevelopment In Young Children With Sickle Cell Disease- 2

Intraoperative Warming: Comparison of Two Temperature Management Systems

Variability of Movement on an Altered Inertial Dynamics Task

The Effect of Eggs on Postprandial Metabolism

Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes

State Immunization Information Systems to Improve HPV Vaccination Rates

GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD

Behavioral Economics and Adherence in Teens (BEAT!)

Comparison of Pre-procedural PCR and Culture-based UTI Assessment Prior to Intravesical Botox Injection